首页 > 最新文献

Pain Medicine最新文献

英文 中文
Do Difficult Encounters Affect Pain Treatment Outcomes? A Prospective Cohort Study.
IF 2.9 3区 医学 Q1 ANESTHESIOLOGY Pub Date : 2025-03-18 DOI: 10.1093/pm/pnaf027
Winnie L Liu, Evelien van Gelderen, Resham Mawalkar, Eric J Wang, Glenn Treisman, Steven P Cohen

Background: Difficult encounters represent an enormous burden and drain on resources in pain medicine, but their effect on outcome has not been studied.

Objective: To determine the effect of "difficult" encounters on chronic pain outcomes.

Methods: In this prospective study, new chronic pain visits were rated by an attending physician and trainee on a 6-point Likert scale and stratified into "difficult" and "non-difficult". The main outcome was successful treatment, defined as a ≥ 2-point reduction in average pain 4 weeks after initiating pharmacological, integrative or injection therapy or 12 weeks after invasive procedures. The secondary outcome was lost-to-follow-up.

Results: Among 428 patients seen for new-patient evaluations, 299 patients had follow-up, of which 127 (42.5%) experienced a positive outcome. Patients involved in difficult encounters were less likely to experience a positive outcome (28% vs. 46%; P = 0.02) than those not involved in difficult encounters. When stratified into quartiles, difficulty continued to be associated with an unsuccessful outcome, with the easiest encounters translating to a 53% success rate vs. 28% for patients involved in the most difficult encounters (P = 0.02). Difficult encounters were not associated with lost-to-follow-up. In multivariable analysis evaluating factors associated with difficultness, ≥10% missed appointments (OR 0.69, 95% CI 0.48 to 0.97; P = 04), nonorganic signs (OR 0.42, 95% CI 0.18 to 0.90; P = 0.03), visiting taking longer than expected (OR 0.49, 95% CI 0.25 to 0.96; P = 0.04) and refusal to try a treatment (OR 0.25, 95% CI 0.08 to 0.70; P = 0.01) were associated with poor outcome.

Conclusions: Difficult encounters can not only lead to administrative burdens, poor ratings and lost revenue, but are also associated with negative outcomes for chronic pain, a condition notoriously associated with difficult visits.

Trial registration: Clinicaltrials.gov (NCT05585619); https://clinicaltrials.gov/study/NCT05585619? id=NCT05585619&rank=1.

{"title":"Do Difficult Encounters Affect Pain Treatment Outcomes? A Prospective Cohort Study.","authors":"Winnie L Liu, Evelien van Gelderen, Resham Mawalkar, Eric J Wang, Glenn Treisman, Steven P Cohen","doi":"10.1093/pm/pnaf027","DOIUrl":"https://doi.org/10.1093/pm/pnaf027","url":null,"abstract":"<p><strong>Background: </strong>Difficult encounters represent an enormous burden and drain on resources in pain medicine, but their effect on outcome has not been studied.</p><p><strong>Objective: </strong>To determine the effect of \"difficult\" encounters on chronic pain outcomes.</p><p><strong>Methods: </strong>In this prospective study, new chronic pain visits were rated by an attending physician and trainee on a 6-point Likert scale and stratified into \"difficult\" and \"non-difficult\". The main outcome was successful treatment, defined as a ≥ 2-point reduction in average pain 4 weeks after initiating pharmacological, integrative or injection therapy or 12 weeks after invasive procedures. The secondary outcome was lost-to-follow-up.</p><p><strong>Results: </strong>Among 428 patients seen for new-patient evaluations, 299 patients had follow-up, of which 127 (42.5%) experienced a positive outcome. Patients involved in difficult encounters were less likely to experience a positive outcome (28% vs. 46%; P = 0.02) than those not involved in difficult encounters. When stratified into quartiles, difficulty continued to be associated with an unsuccessful outcome, with the easiest encounters translating to a 53% success rate vs. 28% for patients involved in the most difficult encounters (P = 0.02). Difficult encounters were not associated with lost-to-follow-up. In multivariable analysis evaluating factors associated with difficultness, ≥10% missed appointments (OR 0.69, 95% CI 0.48 to 0.97; P = 04), nonorganic signs (OR 0.42, 95% CI 0.18 to 0.90; P = 0.03), visiting taking longer than expected (OR 0.49, 95% CI 0.25 to 0.96; P = 0.04) and refusal to try a treatment (OR 0.25, 95% CI 0.08 to 0.70; P = 0.01) were associated with poor outcome.</p><p><strong>Conclusions: </strong>Difficult encounters can not only lead to administrative burdens, poor ratings and lost revenue, but are also associated with negative outcomes for chronic pain, a condition notoriously associated with difficult visits.</p><p><strong>Trial registration: </strong>Clinicaltrials.gov (NCT05585619); https://clinicaltrials.gov/study/NCT05585619? id=NCT05585619&rank=1.</p>","PeriodicalId":19744,"journal":{"name":"Pain Medicine","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2025-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143657950","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Successful non-operative management of symptomatic intradural catheter-tip granuloma in a patient with intrathecal drug delivery system. 对一名使用鞘内给药系统的患者硬膜外导管尖端肉芽肿症状的非手术治疗获得成功。
IF 2.9 3区 医学 Q1 ANESTHESIOLOGY Pub Date : 2025-03-14 DOI: 10.1093/pm/pnaf025
Ratan K Banik, Michel C Park
{"title":"Successful non-operative management of symptomatic intradural catheter-tip granuloma in a patient with intrathecal drug delivery system.","authors":"Ratan K Banik, Michel C Park","doi":"10.1093/pm/pnaf025","DOIUrl":"https://doi.org/10.1093/pm/pnaf025","url":null,"abstract":"","PeriodicalId":19744,"journal":{"name":"Pain Medicine","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2025-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143634198","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Painless lower limb complex regional pain syndrome: A Problem-Based learning discussion.
IF 2.9 3区 医学 Q1 ANESTHESIOLOGY Pub Date : 2025-03-14 DOI: 10.1093/pm/pnaf024
Annie M Cho, Christopher L Robinson, R Jason Yong, Samuel P Ang
{"title":"Painless lower limb complex regional pain syndrome: A Problem-Based learning discussion.","authors":"Annie M Cho, Christopher L Robinson, R Jason Yong, Samuel P Ang","doi":"10.1093/pm/pnaf024","DOIUrl":"https://doi.org/10.1093/pm/pnaf024","url":null,"abstract":"","PeriodicalId":19744,"journal":{"name":"Pain Medicine","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2025-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143634165","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preoperative management of patients with chronic moderate to severe shoulder pain to improve postoperative outcomes. A systematic review.
IF 2.9 3区 医学 Q1 ANESTHESIOLOGY Pub Date : 2025-03-12 DOI: 10.1093/pm/pnaf023
José Manuel López-Millán, Miguel Ángel Ruiz Iban, Jorge Díaz Heredia, Luis Javier Roca Ruiz

Objectives: To assess if implementing interventions to effectively manage preoperative chronic moderate to severe shoulder pain in patients undergoing rotator cuff repair (RCR) can improve shoulder surgery outcomes.

Methods: A systematic review was conducted following the PRISMA and SIGN guidelines. Randomized clinical trials (RCT), metanalysis, systematic revisions and cohort studies in Spanish/English, published within the last 10 years, evaluating interventions to control preoperative chronic moderate to severe shoulder pain in patients undergoing RCR and their impact in postoperative shoulder outcomes were included. Selected records were graded following the 2011 Oxford Centre for Evidence-Based Medicine levels of evidence (OCEBML). RCT were graded using the PEDro scale.

Results: Twenty-nine records were included in the analysis. Evidence suggests that preoperative chronic moderate to severe shoulder pain is the strongest risk factor for postoperative shoulder pain (OCEBML III). Patient-related factors and shoulder pain characteristics can also influence surgery outcomes (OCEBML II/III). Predictors of better shoulder function at 2 years after surgery include higher preoperative scores on the Western Ontario Rotator Cuff index and the Constant-Murley score in the contralateral shoulder (OCEBML III). Preoperative analgesia to control shoulder pain can improve postoperative pain (OCEBML I). Preoperative patient teaching and intensive postoperative follow-up also improve pain intensity and function (OCEBML II).

Discussion: Preoperative chronic shoulder pain together with patient-related factors are significant predictors of postoperative shoulder outcomes, emphasizing the need for proactive pain assessment and tailored therapeutic programs.

{"title":"Preoperative management of patients with chronic moderate to severe shoulder pain to improve postoperative outcomes. A systematic review.","authors":"José Manuel López-Millán, Miguel Ángel Ruiz Iban, Jorge Díaz Heredia, Luis Javier Roca Ruiz","doi":"10.1093/pm/pnaf023","DOIUrl":"https://doi.org/10.1093/pm/pnaf023","url":null,"abstract":"<p><strong>Objectives: </strong>To assess if implementing interventions to effectively manage preoperative chronic moderate to severe shoulder pain in patients undergoing rotator cuff repair (RCR) can improve shoulder surgery outcomes.</p><p><strong>Methods: </strong>A systematic review was conducted following the PRISMA and SIGN guidelines. Randomized clinical trials (RCT), metanalysis, systematic revisions and cohort studies in Spanish/English, published within the last 10 years, evaluating interventions to control preoperative chronic moderate to severe shoulder pain in patients undergoing RCR and their impact in postoperative shoulder outcomes were included. Selected records were graded following the 2011 Oxford Centre for Evidence-Based Medicine levels of evidence (OCEBML). RCT were graded using the PEDro scale.</p><p><strong>Results: </strong>Twenty-nine records were included in the analysis. Evidence suggests that preoperative chronic moderate to severe shoulder pain is the strongest risk factor for postoperative shoulder pain (OCEBML III). Patient-related factors and shoulder pain characteristics can also influence surgery outcomes (OCEBML II/III). Predictors of better shoulder function at 2 years after surgery include higher preoperative scores on the Western Ontario Rotator Cuff index and the Constant-Murley score in the contralateral shoulder (OCEBML III). Preoperative analgesia to control shoulder pain can improve postoperative pain (OCEBML I). Preoperative patient teaching and intensive postoperative follow-up also improve pain intensity and function (OCEBML II).</p><p><strong>Discussion: </strong>Preoperative chronic shoulder pain together with patient-related factors are significant predictors of postoperative shoulder outcomes, emphasizing the need for proactive pain assessment and tailored therapeutic programs.</p>","PeriodicalId":19744,"journal":{"name":"Pain Medicine","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2025-03-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143616668","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Platelet-rich plasma (PRP) injections as a second-line treatment in patients with tendinopathy-related chronic pain and failure of conservative treatment: a systematic review and meta-analysis.
IF 2.9 3区 医学 Q1 ANESTHESIOLOGY Pub Date : 2025-03-12 DOI: 10.1093/pm/pnaf022
Mathieu Nadeau-Vallée, Sami Ellassraoui, Véronique Brulotte

Design: Platelet-rich plasma (PRP) is a popular treatment option in managing chronic tendinopathies, although the literature is inconsistent, mainly because of significant heterogeneity in patient populations. Patients who failed conservative management may respond differently than those who have not undergone first-line treatment. This systematic review and meta-analysis aimed to evaluate the efficacy of PRP injections in reducing pain and improving function in patients with chronic tendinopathy who failed conservative treatment. A comprehensive search of Medline, Embase, Cochrane Library, Cinahl Complete and Dissertations & Theses Global was conducted to identify randomized controlled trials comparing the effect of PRP versus non-surgical treatments on pain and functional outcomes in adult non-responders to conservative management.

Results: A total of 9 RCTs involving 488 patients were included in the review. Of those, 6 studies at low risk of bias were included in the meta-analysis. PRP significantly reduced pain at both 6 and 12 months compared to control treatments (mean difference: -0.83 [95% CI: -1.61 to -0.04] at 6 months; and -1.11 [95% CI: -2.10 to -0.12] at 12 months). This effect was also seen at 24 months, although based on limited data. Subgroup analysis revealed no significant differences in pain reduction between upper and lower limb tendinopathies. Functional improvement was observed in some studies, though the heterogeneity in outcome measures precluded a pooled analysis. Heterogeneity was substantial across studies, likely due to differences in PRP preparation, site of tendinopathy, and study methodologies.

Conclusion: Despite these limitations, the findings suggest that PRP reduces pain in patients suffering from chronic tendinopathy who have not responded to first-line therapies. Further high-quality research with standardized protocols and longer follow-up is necessary to confirm PRP's long-term efficacy and safety.

{"title":"Platelet-rich plasma (PRP) injections as a second-line treatment in patients with tendinopathy-related chronic pain and failure of conservative treatment: a systematic review and meta-analysis.","authors":"Mathieu Nadeau-Vallée, Sami Ellassraoui, Véronique Brulotte","doi":"10.1093/pm/pnaf022","DOIUrl":"https://doi.org/10.1093/pm/pnaf022","url":null,"abstract":"<p><strong>Design: </strong>Platelet-rich plasma (PRP) is a popular treatment option in managing chronic tendinopathies, although the literature is inconsistent, mainly because of significant heterogeneity in patient populations. Patients who failed conservative management may respond differently than those who have not undergone first-line treatment. This systematic review and meta-analysis aimed to evaluate the efficacy of PRP injections in reducing pain and improving function in patients with chronic tendinopathy who failed conservative treatment. A comprehensive search of Medline, Embase, Cochrane Library, Cinahl Complete and Dissertations & Theses Global was conducted to identify randomized controlled trials comparing the effect of PRP versus non-surgical treatments on pain and functional outcomes in adult non-responders to conservative management.</p><p><strong>Results: </strong>A total of 9 RCTs involving 488 patients were included in the review. Of those, 6 studies at low risk of bias were included in the meta-analysis. PRP significantly reduced pain at both 6 and 12 months compared to control treatments (mean difference: -0.83 [95% CI: -1.61 to -0.04] at 6 months; and -1.11 [95% CI: -2.10 to -0.12] at 12 months). This effect was also seen at 24 months, although based on limited data. Subgroup analysis revealed no significant differences in pain reduction between upper and lower limb tendinopathies. Functional improvement was observed in some studies, though the heterogeneity in outcome measures precluded a pooled analysis. Heterogeneity was substantial across studies, likely due to differences in PRP preparation, site of tendinopathy, and study methodologies.</p><p><strong>Conclusion: </strong>Despite these limitations, the findings suggest that PRP reduces pain in patients suffering from chronic tendinopathy who have not responded to first-line therapies. Further high-quality research with standardized protocols and longer follow-up is necessary to confirm PRP's long-term efficacy and safety.</p>","PeriodicalId":19744,"journal":{"name":"Pain Medicine","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2025-03-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143616665","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predicting adherence and clinical response of cognitive behavioral therapy among individuals with chronic low back pain plus depressive symptoms: A secondary analysis of a randomized controlled trial.
IF 2.9 3区 医学 Q1 ANESTHESIOLOGY Pub Date : 2025-03-10 DOI: 10.1093/pm/pnaf020
Juan P Sanabria-Mazo, Estíbaliz Royuela-Colomer, Jaime Navarrete, Carla Rodríguez-Freire, Brenda Robles, Lance M McCracken, Albert Feliu-Soler, Juan V Luciano

Background: Identifying predictors for adherence and clinical response to psychological therapies is essential for improving individual treatment outcomes.

Objective: To explore predictors of adherence and clinical response among individuals with co-occurring chronic low back pain (CLBP) and depression receiving cognitive behavioral therapy (CBT).

Methods: This study employs a secondary analysis of data from a randomized controlled trial (NCT04140838), including 156 individuals with CLBP plus depressive symptoms who received CBT. Multiple linear regression analyses were conducted to assess the predictive power of sociodemographic, health status, pain-related, and therapy-related variables on adherence and clinical response. Adherence was measured by therapy progress (number of completed sessions) and therapy completion (attendance at least six out of eight sessions). Clinical response was assessed by a clinically relevant reduction in posttreatment pain interference.

Results: Older age, higher therapy credibility, and higher education level predicted greater therapy progress, while higher therapy credibility and lower baseline stress levels predicted greater therapy completion. In addition, higher opioid use, baseline pain interference, and baseline depression levels predicted lower clinical response; in contrast, higher behavioral activation levels, older age, and unemployment predicted higher clinical response.

Conclusion: Therapy credibility, age, and education level are key predictors of adherence, and baseline levels of pain interference, depression, and behavioral activation are key predictors of clinical response. These findings may inform opportunities to develop more effective personalized therapeutic plans for individuals with CLBP and depression.

{"title":"Predicting adherence and clinical response of cognitive behavioral therapy among individuals with chronic low back pain plus depressive symptoms: A secondary analysis of a randomized controlled trial.","authors":"Juan P Sanabria-Mazo, Estíbaliz Royuela-Colomer, Jaime Navarrete, Carla Rodríguez-Freire, Brenda Robles, Lance M McCracken, Albert Feliu-Soler, Juan V Luciano","doi":"10.1093/pm/pnaf020","DOIUrl":"https://doi.org/10.1093/pm/pnaf020","url":null,"abstract":"<p><strong>Background: </strong>Identifying predictors for adherence and clinical response to psychological therapies is essential for improving individual treatment outcomes.</p><p><strong>Objective: </strong>To explore predictors of adherence and clinical response among individuals with co-occurring chronic low back pain (CLBP) and depression receiving cognitive behavioral therapy (CBT).</p><p><strong>Methods: </strong>This study employs a secondary analysis of data from a randomized controlled trial (NCT04140838), including 156 individuals with CLBP plus depressive symptoms who received CBT. Multiple linear regression analyses were conducted to assess the predictive power of sociodemographic, health status, pain-related, and therapy-related variables on adherence and clinical response. Adherence was measured by therapy progress (number of completed sessions) and therapy completion (attendance at least six out of eight sessions). Clinical response was assessed by a clinically relevant reduction in posttreatment pain interference.</p><p><strong>Results: </strong>Older age, higher therapy credibility, and higher education level predicted greater therapy progress, while higher therapy credibility and lower baseline stress levels predicted greater therapy completion. In addition, higher opioid use, baseline pain interference, and baseline depression levels predicted lower clinical response; in contrast, higher behavioral activation levels, older age, and unemployment predicted higher clinical response.</p><p><strong>Conclusion: </strong>Therapy credibility, age, and education level are key predictors of adherence, and baseline levels of pain interference, depression, and behavioral activation are key predictors of clinical response. These findings may inform opportunities to develop more effective personalized therapeutic plans for individuals with CLBP and depression.</p>","PeriodicalId":19744,"journal":{"name":"Pain Medicine","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2025-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143597415","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of a natural herbal topical analgesic versus oral paracetamol in patients with soft tissue injury. A randomized, double-blind, placebo-controlled study.
IF 2.9 3区 医学 Q1 ANESTHESIOLOGY Pub Date : 2025-03-05 DOI: 10.1093/pm/pnaf006
Marwa Toumia, Randa Dhaoui, Sarra Sassi, Cyrine Kouraichi, Khaoula Bel Haj Ali, Adel Sekma, Arij Bakir, Rahma Jaballah, Hajer Yaakoubi, Rym Youssef, Asma Zorgati, Kaouthar Beltaief, Zied Mezgar, Mariem Khrouf, Amira Sghaier, Nahla Jerbi, Imen Zemni, Wahid Bouida, Mohamed Habib Grissa, Jamel Saad, Hamdi Boubaker, Riadh Boukef, Mohamed Amine Msolli, Semir Nouira

Objective: This study aims to evaluate the effectiveness and tolerability of a phytotherapeutic topical gel (Douloff®) compared to oral paracetamol for acute pain resulting from minor limb soft tissue injuries.

Methods: A prospective, multicenter, randomized, double-blind study conducted over 13 months in three EDs. Patients aged 18 years and older, with minor limb soft tissue injuries, were randomized into Douloff® (n = 765) and paracetamol (n = 750) groups. The primary outcome was the pain resolution rate (reduction of at least 50% of pain intensity, measured by the numeric rating scale (NRS) on active motion at day-7compared to NRS at discharge). Secondary outcomes included time to pain resolution, rescue analgesia, patient satisfaction and adverse events.

Results: The groups were comparable in terms of baseline characteristics. On day-7, resolution of pain was observed in 641 patients (83.7%) in Douloff® group versus 535 patients (71.3%) in paracetamol group (OR 1.27; 95% CI 1.015-1.6; p = 0.02). Median time to reach pain resolution was 4.5 ± 2.9 days in Douloff® group compared with 5.6 ± 3.3 days in paracetamol group (p < 0.001). Patients in Douloff® group required less rescue analgesics (48.2%) compared to paracetamol group (59.1%) (-10.9%, 95% CI -15.89 to -5.9; p < 0.001). No major adverse events were observed in either group, and 89.4% of patients in Douloff® group were satisfied, compared to 92.5% in the paracetamol group (p < 0.001).

Conclusion: Douloff®, a topical herbal paste, is superior to oral paracetamol in the management of acute pain related to soft tissue injuries. It can be considered as an alternative to conventional analgesics.

{"title":"Efficacy of a natural herbal topical analgesic versus oral paracetamol in patients with soft tissue injury. A randomized, double-blind, placebo-controlled study.","authors":"Marwa Toumia, Randa Dhaoui, Sarra Sassi, Cyrine Kouraichi, Khaoula Bel Haj Ali, Adel Sekma, Arij Bakir, Rahma Jaballah, Hajer Yaakoubi, Rym Youssef, Asma Zorgati, Kaouthar Beltaief, Zied Mezgar, Mariem Khrouf, Amira Sghaier, Nahla Jerbi, Imen Zemni, Wahid Bouida, Mohamed Habib Grissa, Jamel Saad, Hamdi Boubaker, Riadh Boukef, Mohamed Amine Msolli, Semir Nouira","doi":"10.1093/pm/pnaf006","DOIUrl":"https://doi.org/10.1093/pm/pnaf006","url":null,"abstract":"<p><strong>Objective: </strong>This study aims to evaluate the effectiveness and tolerability of a phytotherapeutic topical gel (Douloff®) compared to oral paracetamol for acute pain resulting from minor limb soft tissue injuries.</p><p><strong>Methods: </strong>A prospective, multicenter, randomized, double-blind study conducted over 13 months in three EDs. Patients aged 18 years and older, with minor limb soft tissue injuries, were randomized into Douloff® (n = 765) and paracetamol (n = 750) groups. The primary outcome was the pain resolution rate (reduction of at least 50% of pain intensity, measured by the numeric rating scale (NRS) on active motion at day-7compared to NRS at discharge). Secondary outcomes included time to pain resolution, rescue analgesia, patient satisfaction and adverse events.</p><p><strong>Results: </strong>The groups were comparable in terms of baseline characteristics. On day-7, resolution of pain was observed in 641 patients (83.7%) in Douloff® group versus 535 patients (71.3%) in paracetamol group (OR 1.27; 95% CI 1.015-1.6; p = 0.02). Median time to reach pain resolution was 4.5 ± 2.9 days in Douloff® group compared with 5.6 ± 3.3 days in paracetamol group (p < 0.001). Patients in Douloff® group required less rescue analgesics (48.2%) compared to paracetamol group (59.1%) (-10.9%, 95% CI -15.89 to -5.9; p < 0.001). No major adverse events were observed in either group, and 89.4% of patients in Douloff® group were satisfied, compared to 92.5% in the paracetamol group (p < 0.001).</p><p><strong>Conclusion: </strong>Douloff®, a topical herbal paste, is superior to oral paracetamol in the management of acute pain related to soft tissue injuries. It can be considered as an alternative to conventional analgesics.</p>","PeriodicalId":19744,"journal":{"name":"Pain Medicine","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2025-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143567778","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The NIH HEAL pain common data elements (CDE): a great start but a long way to the finish line. 美国国立卫生研究院疼痛通用数据元素:良好的开端,但距离终点还有很长的路要走。
IF 2.9 3区 医学 Q1 ANESTHESIOLOGY Pub Date : 2025-03-01 DOI: 10.1093/pm/pnae110
Meredith C B Adams, Afton L Hassett, Daniel J Clauw, Robert W Hurley

Background: The National Institutes of Health (NIH) Pain Common Data Elements (CDEs) provide a standardized framework for pain research, but their implementation and interpretation present challenges.

Objectives: To review the NIH CDE Program's selected pain domains, provide best practices for implementing required questions, and offer a checklist for appropriate CDE use in clinical trials and secondary data analysis. This work analyzed the 10 core pain research domains selected by the NIH CDE Program and discuss their limitations and considerations for use.

Results: The manuscript provides an overview of the 10 core pain research domains, including pain intensity, interference, physical function, sleep, catastrophizing, depression, anxiety, global impression of change, substance use screening, and quality of life. It offers sample scenarios for implementing required questions and presents a checklist to guide researchers in using pain CDEs effectively for clinical trials and secondary data analysis.

Conclusion: Key challenges identified include contextual variability, lack of validation across all pain conditions and populations, and potential misuse or misinterpretation of measures. This work proposes solutions such as supplementary measures, context-specific guidance, comprehensive training programs, and ongoing refinement of the CDE framework. While NIH Pain CDEs are valuable tools for standardizing pain assessment in research, addressing challenges in their implementation and interpretation is crucial for improving the consistency, validity, and interpretability of pain research data, ultimately advancing the field and enhancing patient care.

背景:美国国立卫生研究院(NIH)疼痛通用数据元素(CDE)为疼痛研究提供了一个标准化框架,但其实施和解释却面临挑战:回顾美国国立卫生研究院 CDE 计划选定的疼痛领域,提供实施所需问题的最佳实践,并提供一份在临床试验和二次数据分析中适当使用 CDE 的核对表:这项工作分析了美国国立卫生研究院 CDE 计划选定的十个核心疼痛研究领域,并讨论了其局限性和使用时的注意事项:手稿概述了十个核心疼痛研究领域,包括疼痛强度、干扰、身体功能、睡眠、灾难化、抑郁、焦虑、总体变化印象、药物使用筛查和生活质量。该报告提供了实施所需问题的示例方案,并提供了一份核对表,以指导研究人员在临床试验和二次数据分析中有效使用疼痛 CDE:讨论:已确定的主要挑战包括环境的可变性、缺乏对所有疼痛状况和人群的验证,以及对测量方法的潜在误用或误解。这项工作提出了一些解决方案,如补充措施、针对具体情况的指导、综合培训计划以及 CDE 框架的不断完善:尽管 NIH 疼痛 CDE 是研究中标准化疼痛评估的宝贵工具,但解决其实施和解释中的挑战对于提高疼痛研究数据的一致性、有效性和可解释性至关重要,最终将推动该领域的发展并加强对患者的护理。
{"title":"The NIH HEAL pain common data elements (CDE): a great start but a long way to the finish line.","authors":"Meredith C B Adams, Afton L Hassett, Daniel J Clauw, Robert W Hurley","doi":"10.1093/pm/pnae110","DOIUrl":"10.1093/pm/pnae110","url":null,"abstract":"<p><strong>Background: </strong>The National Institutes of Health (NIH) Pain Common Data Elements (CDEs) provide a standardized framework for pain research, but their implementation and interpretation present challenges.</p><p><strong>Objectives: </strong>To review the NIH CDE Program's selected pain domains, provide best practices for implementing required questions, and offer a checklist for appropriate CDE use in clinical trials and secondary data analysis. This work analyzed the 10 core pain research domains selected by the NIH CDE Program and discuss their limitations and considerations for use.</p><p><strong>Results: </strong>The manuscript provides an overview of the 10 core pain research domains, including pain intensity, interference, physical function, sleep, catastrophizing, depression, anxiety, global impression of change, substance use screening, and quality of life. It offers sample scenarios for implementing required questions and presents a checklist to guide researchers in using pain CDEs effectively for clinical trials and secondary data analysis.</p><p><strong>Conclusion: </strong>Key challenges identified include contextual variability, lack of validation across all pain conditions and populations, and potential misuse or misinterpretation of measures. This work proposes solutions such as supplementary measures, context-specific guidance, comprehensive training programs, and ongoing refinement of the CDE framework. While NIH Pain CDEs are valuable tools for standardizing pain assessment in research, addressing challenges in their implementation and interpretation is crucial for improving the consistency, validity, and interpretability of pain research data, ultimately advancing the field and enhancing patient care.</p>","PeriodicalId":19744,"journal":{"name":"Pain Medicine","volume":" ","pages":"146-155"},"PeriodicalIF":2.9,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11879210/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142569227","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Single arm feasibility trial of a mobile application for adolescent migraine management. 青少年偏头痛管理移动应用单臂可行性试验
IF 2.9 3区 医学 Q1 ANESTHESIOLOGY Pub Date : 2025-03-01 DOI: 10.1093/pm/pnae111
Amy E Noser, Abigail S Robbertz, James Peugh, Marielle Kabbouche, Joanne Kacperski, Scott W Powers, Andrew D Hershey, Kevin A Hommel
{"title":"Single arm feasibility trial of a mobile application for adolescent migraine management.","authors":"Amy E Noser, Abigail S Robbertz, James Peugh, Marielle Kabbouche, Joanne Kacperski, Scott W Powers, Andrew D Hershey, Kevin A Hommel","doi":"10.1093/pm/pnae111","DOIUrl":"10.1093/pm/pnae111","url":null,"abstract":"","PeriodicalId":19744,"journal":{"name":"Pain Medicine","volume":" ","pages":"170-172"},"PeriodicalIF":2.9,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11879155/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142581895","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Enhancing early career development in pain medicine: the comprehensive role of mentorship. 促进疼痛医学早期职业发展:师徒关系的综合作用。
IF 2.9 3区 医学 Q1 ANESTHESIOLOGY Pub Date : 2025-03-01 DOI: 10.1093/pm/pnae128
Yashar Eshraghi, Meredith Barad, Scott Pritzlaff, Trent Emerick, Sayed Wahezi, Magdalena Anitescu, Lynn Kohan

Mentorship plays a vital role in pain medicine, guiding professionals from medical training through independent practice. This article explores how mentorship fosters research, enhances clinical competence, and promotes multidisciplinary collaboration. Drawing on insights from leading institutions, we propose a structured mentorship framework tailored to different career stages. Effective mentorship cultivates research skills, expands academic networks, and provides early exposure to the field, shaping long-term career trajectories. It also strengthens clinical expertise, encourages cross-disciplinary collaboration, and advances diversity, equity, and inclusion in medicine. Structured academic mentorship models offer longitudinal guidance for sustained professional development. By aligning mentor-mentee goals and ensuring consistent support, mentorship programs maximize professional growth and ultimately improve patient outcomes. This article outlines key strategies and tools for building effective mentorship programs, emphasizing their transformative impact on the field of pain medicine.

{"title":"Enhancing early career development in pain medicine: the comprehensive role of mentorship.","authors":"Yashar Eshraghi, Meredith Barad, Scott Pritzlaff, Trent Emerick, Sayed Wahezi, Magdalena Anitescu, Lynn Kohan","doi":"10.1093/pm/pnae128","DOIUrl":"10.1093/pm/pnae128","url":null,"abstract":"<p><p>Mentorship plays a vital role in pain medicine, guiding professionals from medical training through independent practice. This article explores how mentorship fosters research, enhances clinical competence, and promotes multidisciplinary collaboration. Drawing on insights from leading institutions, we propose a structured mentorship framework tailored to different career stages. Effective mentorship cultivates research skills, expands academic networks, and provides early exposure to the field, shaping long-term career trajectories. It also strengthens clinical expertise, encourages cross-disciplinary collaboration, and advances diversity, equity, and inclusion in medicine. Structured academic mentorship models offer longitudinal guidance for sustained professional development. By aligning mentor-mentee goals and ensuring consistent support, mentorship programs maximize professional growth and ultimately improve patient outcomes. This article outlines key strategies and tools for building effective mentorship programs, emphasizing their transformative impact on the field of pain medicine.</p>","PeriodicalId":19744,"journal":{"name":"Pain Medicine","volume":" ","pages":"129-130"},"PeriodicalIF":2.9,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142847293","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Pain Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1